The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The bicyclam AMD3100 story
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., et al. (2002) · Nature Immunology · doi:10.1038/ni813 · Cited by 1,332
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
Donzella, G. A., Schols, D., Lin, S. W., Esté, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., DeClercq, E., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-072 · Cited by 760
Self-citationInhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Hendrix, C. W., Flexner, C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., Bridger, G., & Henson, G. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1667-1673.2000 · Cited by 504
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 471
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
Hatse, S., Princen, K., Bridger, G., De Clercq, E., & Schols, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03143-5 · Cited by 448
Self-citationKoshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., et al. (2000) · PubMed · Cited by 424
A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection
Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1389 · Cited by 398
Doranz, B. J., Grovit-Ferbas, K., Sharron, M. P., Mao, S.-H., Goetz, M. B., Daar, E. S., Doms, R. W., & O'Brien, W. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1395 · Cited by 336
De Clercq, E., Yamamoto, N., Pauwels, R., Balzarini, J., Witvrouw, M., De Vreese, K., Debyser, Z., Rosenwirth, B., Peichl, P., & Datema, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.668 · Cited by 296
Self-citationGerlach, L. O., Skerlj, R. T., Bridger, G. J., & Schwartz, T. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010429200 · Cited by 260
Matthys, P., Hatse, S., Vermeire, K., Wuyts, A., Bridger, G., Henson, G. W., De Clercq, E., Billiau, A., & Schols, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4686 · Cited by 251
Self-citationAntiviral therapy for human immunodeficiency virus infections
De Clercq, E. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.2.200 · Cited by 246
Self-citationDe Clercq, E., Yamamoto, N., Pauwels, R., Baba, M., Schols, D., Nakashima, H., Balzarini, J., Debyser, Z., Murrer, B. A., & Schwartz, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5286 · Cited by 242
Self-citationBicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor Fusin/CXCR-4
Schols, D., Esté, J. A., Henson, G., & De Clercq, E. (1997) · Antiviral Research · doi:10.1016/s0166-3542(97)00025-9 · Cited by 220
Self-citationAMD3100, a CxCR4 Antagonist, Attenuates Allergic Lung Inflammation and Airway Hyperreactivity
Lukacs, N. W., Berlin, A., Schols, D., Skerlj, R. T., & Bridger, G. J. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62562-x · Cited by 207
Ichiyama, K., Yokoyama-Kumakura, S., Tanaka, Y., Tanaka, R. J., Hirose, K., Bannai, K., Edamatsu, T., Yanaka, M., Niitani, Y., Miyano‐Kurosaki, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630420100 · Cited by 156
Metal Ion Enhanced Binding of AMD3100 to Asp262 in the CXCR4 Receptor
Gerlach, L. O., Jakobsen, J. S., Kepp, K. P., ROSENKILDE, M. M., Skerlj, R. T., Ryde, U., Bridger, G. J., & Schwartz, T. W. (2002) · Biochemistry · doi:10.1021/bi0264770 · Cited by 140
The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
de Vreese, K., Kofler-Mongold, V., Leutgeb, C., Weber, V., Vermeire, K., Schacht, S., Anné, J., Clercq, E. D., DATEMA, R., & Werner, G. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.689-696.1996 · Cited by 130
Hatse, S., Princen, K., Gerlach, L., Bridger, G. J., Henson, G. W., Clercq, E. D., Schwartz, T. W., & Schols, D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23060-1 · Cited by 118
Inhibition of HIV Infection by Bicyclams, Highly Potent and Specific CXCR4 Antagonists
Clercq, E. D. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26490-7 · Cited by 114
Safe Use of the CXCR4 Inhibitor ALX40-4C in Humans
Doranz, B. J., Filion, L. G., Díaz‐Mitoma, F., SITAR, D. S., Sahai, J. V., Baribaud, F., Orsini, M. J., Benovic, J., Cameron, D. W., & Doms, R. W. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220151126508 · Cited by 112
Schols, D., Esté, J. A., Cabrera, C., & Clercq, E. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4032-4037.1998 · Cited by 109
Esté, J. A., Cabrera, C., Blanco, J., Gutiérrez, A., Bridger, G. J., Henson, G. W., Clotet, B., Schols, D., & Clercq, E. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5577-5585.1999 · Cited by 107
DATEMA, R., Rabin, L. B., Hincenbergs, M., Moreno, M. B., Warren, S., Linquist-Stepps, V. D., Rosenwirth, B., SEIFERT, J. ‐., & McCune, J. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.750 · Cited by 102
Esté, J. A., Cabrera, C., Clercq, E. D., Struyf, S., Damme, J. V., Bridger, G. J., Skerlj, R. T., Abrams, M. J., Henson, G. W., Gutiérrez, A., et al. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23157-6 · Cited by 101
Clercq, E. D. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00411-3 · Cited by 26
Cited by
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells
Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., & Keshet, E. (2006) · Cell · doi:10.1016/j.cell.2005.10.036 · Cited by 1,126
Application of Metal Coordination Chemistry To Explore and Manipulate Cell Biology
Haas, K. L., & Franz, K. J. (2009) · Chemical Reviews · doi:10.1021/cr900134a · Cited by 984
Broxmeyer, H. E., Orschell, C. M., Clapp, D. W., Hangoc, G., Cooper, S., Plett, P. A., Liles, W. C., Li, X., Graham-Evans, B., Campbell, T. B., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041385 · Cited by 970
Metadata
- Authors
- De Clercq, E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-07
- Volume
- 2
- Issue
- 7
- Pages
- 581-587
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1548997088
- Cited by
- 460
- References
- 31
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.